Washout based on mean ± SD of t½ [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2022-09-26 19:35 (134 d 06:06 ago) – Posting: # 23322
Views: 1,094

Hi Imph,

❝ I would like to know if this method can be applied to each pharmacokinetic measurement, for example to determine the duration of the sampling (5 x t1/2) or to calculate the predose limit of 5% Cmax when the Cmax is provided in the literature under mean+/-SD.


In principle, yes. I prefer to start with a single dose profile (even if read from a published figure) and perform nonparametric superposition.

❝ Why plan for 95% coverage (z0.95 = 1.96), is it related to alpha =5%.


Convention. You can use a more conservative value.

❝ In the reference you gave, a normal distribution is assumed, but pharmacokinetic measurements do not generally follow a normal distribution but a log-normal one. Does this method still apply?


You are right. But if the arithmetic mean ± SD is all you have… If you have results for the geometric mean, better, of course.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
17 visitors (0 registered, 17 guests [including 7 identified bots]).
Forum time: 00:42 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5